Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Biotech VC (Venture Capital) Funds in Finland in February 2025

Last updated: Feb 2025 A list of 50 VC (Venture Capital) funds that invest in Biotech startups based in Finland. We rank investors based on the number of investments they made in Biotech companies from Finland. We update this investor list every month.

Top 50 Biotech VC (Venture Capital) Funds in Finland in February 2025

Investor	Biotech Finland investments
Tesi	11
Lifeline Ventures	10
Business Finland	9
Finnvera Venture Capital	8
Voima Ventures	8
Butterfly Ventures	6
Springvest	5
Icebreaker.vc	4
Nordic Foodtech VC	3
Innovestor	3
Inventure	2
Finnish Climate Fund	2
Sitra	2
Nordic Science Investments	2
VTT Ventures	2
European Investment Bank	2
Sofinnova Partners	2
Pontos Group	2
EQT Life Sciences	2
Fazer	2
HealthCap	2
Stephen Industries	2
Takoa Invest	1
Aqua Spark	1
Fortum	1
Green Campus Innovations Oy	1
Midinvest Management	1
Oy Hammaren & Co Ab	1
Creathor Ventures	1
Advent Life Sciences	1
Cor Group	1
Nordea	1
Lynx Capital	1
Kiilto Ventures	1
Horizon 2020	1
Gaingels	1
CPT Capital	1
Metsola Ventures	1
Conor Venture Partners	1
Illusian Founder Office	1
Zhejiang Huahai Pharmaceutical	1
Broadview Ventures	1
Stockholm Techstars Accelerator	1
HTGF \| High-Tech Gruenderfonds	1
Moomin Characters	1
K5 Global	1
Valio	1
Ananda Impact Ventures	1
Thames Trust	1
Athensmed	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570

Investment focus

Software, Manufacturing, Health Care
Funding Round, Series A, Series B
Finland, United States, Argentina

Portfolio highlights

Seaber — Seaber is a cloud-based real-time planning, optimisation and communication solution for bulk cargo & vessels. Our solution improves the efficiency of bulk & break bulk charterers, shipowners & brokers through schedule planning and stakeholder communications over the lifecycle of a voyage.
Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
TactoTek — Set your imagination free and create user experiences with the help of sustainable smart molded structures.

Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Funding Round
Finland, United States, United Kingdom

Portfolio highlights

Louhe — Enabling Data-Driven Security Culture With Explainable AI. LOUHE recognises anomalies and creates smart situational awareness with explainable artificial intelligence.
In Parallel — In Parallel aligns strategy and execution, enabling organizations to thrive in complexity and adapt to change. Our Intelligent Operating Model bridges the gap between strategy and operations. Founded in 2023.
In Parallel — In Parallel aligns strategy and execution, enabling organizations to thrive in complexity and adapt to change. Our Intelligent Operating Model bridges the gap between strategy and operations. Founded in 2023.

Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.

Investment focus

Software, Biotechnology, SaaS
Seed, Grant, Funding Round
Finland, United States, United Kingdom

Portfolio highlights

Grafintec — Grafintec Oy is a Finnish company focused on developing and utilizing carbon technology to produce graphite. Graphite is an essential material in many industries, particularly in energy storage, electronics, and battery technologies, due to its unique properties such as high conductivity, heat resistance, and stability.
Liquid Sun — Liquid Sun Ltd. We fight against climate change by recoding CO2 emissions to fossil-free fuels and chemicals. Our technology is based low temperature electrolyzers.
PrecisionPhage — PrecisionPhage is a biotech business that specializes on bacteriophage technologies.

Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.

Investment focus

Health Care, Software, Information Technology
Seed, Funding Round, Series A
Finland, United States, Switzerland

Portfolio highlights

AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
Nexstim — Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder.The company was founded in2000 and is headquartered in Helsinki, Southern Finland.
Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

Investment focus

Biotechnology, Health Care, Medical Device
Seed, Pre-Seed, Funding Round
Finland, Sweden, Norway

Portfolio highlights

Betolar — Betolar is a new materials startup specialized in new geopolymer-based carbon-neutral construction materials for the construction industry and circular economy.
Liquid Sun — Liquid Sun Ltd. We fight against climate change by recoding CO2 emissions to fossil-free fuels and chemicals. Our technology is based low temperature electrolyzers.
Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.

Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.

Investment focus

Health Care, Software, Information Technology
Seed, Funding Round, Pre-Seed
Finland, Sweden, Norway

Portfolio highlights

Hypertype — Smartest email experience ever made.
Flow Computing — Flow's Parallel Processing Unit (PPU) gives 100X CPU performance for demanding applications, such as locally-hosted AI and general-purpose parallel computing.
Happy Plant Protein — Changing the way plant proteins are made

The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.

Investment focus

Biotechnology, Health Care, Energy
Series A, Funding Round, Seed
Finland

Portfolio highlights

Desentum — Allergen immunotherapy that is effective, safe, patient-friendly and approved by the regulatory authorities.
Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.

Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.

Investment focus

Software, Information Technology, Artificial Intelligence
Pre-Seed, Seed, Series A
Finland, Sweden, Estonia

Portfolio highlights

Modash.io — High performing marketing teams use Modash to find, analyze and monitor influencers at scale all over the world. Join them today.
Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
Grid Raven — Maximize the safety and capacity of your grid with accurate ratings based on our hyper-local weather model that accounts with every tree, building and hill.

We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food

Investment focus

Biotechnology, Life Science, Water
Seed, Series A, Funding Round
Finland, Sweden, Denmark

Portfolio highlights

EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
Endless Food Co — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
Happy Plant Protein — Changing the way plant proteins are made

Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.

Investment focus

Software, Health Care, Manufacturing
Seed, Funding Round, Series A
Finland, Denmark, Sweden

Portfolio highlights

MailMoo — Record one video. MailMoo personalizes it to thousands of leads.
Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
Neumirna Therapeutics — Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions.

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Series B
Finland, Sweden, Denmark

Portfolio highlights

Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Biomatter — Biomatter Designs is pioneering the technologies for generative protein design at the intersection of synthetic biology and AI.
Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.

The Climate Fund focuses on combating climate change, boosting low-carbon industry and promoting digitalisation.

Investment focus

Biotechnology, Food Processing, Renewable Energy
Debt Financing, Funding Round
Finland

Portfolio highlights

AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
Hycamite TCD Technologies — Hycamite is decarbonising industry using its proprietary methane pyrolysis technology. It provides its industrial clients with low-carbon hydrogen and sustainable carbon products for demanding applications.

Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.

Investment focus

Health Care, Biotechnology, Therapeutics
Funding Round, Series A, Series C
Finland, The Netherlands

Portfolio highlights

Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
SET Ventures — Venture capital firm focused on digital technologies for a carbon-free energy system

We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.

Investment focus

Apps, Food Processing, Food and Beverage
Seed
Finland

Portfolio highlights

Acouspin — Acouspin provides ultrasonic-enhanced, AI-driven seamless technology for efficient and flexible nanofiber production, allowing producers to attain precision without specific expertise.
PrecisionPhage — PrecisionPhage is a biotech business that specializes on bacteriophage technologies.
Phenaros Pharmaceuticals — Data-centric drug discovery with AI, Phenomics and Automation.

VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?

Investment focus

Biotechnology, Manufacturing, 3D Technology
Seed, Funding Round, Series A
Finland

Portfolio highlights

Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Investment focus

Biotechnology, Health Care, Energy
Debt Financing, Post-IPO Debt, Funding Round
Germany, France, The Netherlands

Portfolio highlights

Amadix — Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and utility through international multicentre studies, the products will be commercialized worldwide.The most advancedproduct developed by Amadix is Colofast, an innovative non-invasive screening signature for colorectal cancer (CRC) and advanced adenoma diagnosis in blood designed to solve a significant health priority: the high mortality rate due to colon cancer worldwide (around half of the diagnosed patients).Amadix team consist of industry veterans with robust expertise in the Oncology Diagnostic area. They are a top level management team with international experience in cancer diagnostics, the pharmaceutical industry, the biotechnology sector and intellectual property. Amadix also has independent board members with international profiles and many years of experience in oncology and diagnostics, who advise the management team on strategy, commercialization and business development in Europe and the US.
Greenlight Biosciences — Next Generation Crop Protection
Azienda Comprensoriale Acquedottistica — ACA Spa is an integrated water service company.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
nChroma Bio — nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques.
Berry Street — Nutrition therapy by registered dietitians covered by insurance.

Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.

Investment focus

Genetics, Hospital, Automotive
Funding Round
Finland

Portfolio highlights

Valmet Automotive — Valmet Automotive, a Uusikaupunki, Finland-based electric vehicle developer and manufacturer. Valmet Automotive provides engineering, manufacturing and business services for the automotive industry. In 2009, the company generated net sales of â‚¬56m and employed some 800 people. It manufactures Porsche Cayman sports cars, electric Garia golf carsand THINK City urban cars in Uusikaupunki, Finland. Cuca
Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, The Netherlands, Switzerland

Portfolio highlights

XyloCor Therapeutics — XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease. The company's service focuses on developing gene therapy to stimulate the formation of new coronary blood vessels and serve areas of the heart that are not receiving adequate blood supply, enabling patientswith refractory angina who exhausted pharmacologic options to cure their cardiovascular diseases painlessly and cost effectively.
Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.

Fazer Group mission is to create taste sensations. Customer orientation, quality and operations are based.

Investment focus

Biotechnology, Food Processing
Series A, Series B, Funding Round
Finland

Portfolio highlights

Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
United States, Sweden, France

Portfolio highlights

Kivu Bioscience — At Kivu Bioscience, we leverage advanced, next-generation proprietary ADC technologies to deliver more precise and effective cancer treatments.
Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.
SynOx Therapeutics — SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors. SynOx Therapeutics raises EUR 37m to develop emactuzumab to improve the lives of patients with tenosynovial giant cell tumors November 16, 2020. It was founded in 2020 and is located in Dublin City, Ireland.

We fund futurebreakthroughs

Investment focus

Apps, Water, Energy
Seed, Funding Round, Series A
Finland

Portfolio highlights

Flow Computing — Flow's Parallel Processing Unit (PPU) gives 100X CPU performance for demanding applications, such as locally-hosted AI and general-purpose parallel computing.
Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
Hycamite TCD Technologies — Hycamite is decarbonising industry using its proprietary methane pyrolysis technology. It provides its industrial clients with low-carbon hydrogen and sustainable carbon products for demanding applications.

Takoa Invest is a Finnish family-owned investment company that owns and develops companies and properties with growth potential in Finland and abroad. Takoa Invest is a Finnish family-owned investment company. It owns and develops companies and properties with growth potential in Finland and abroad.

Investment focus

Biotechnology, Mobile, Retail
Seed, Series B, Series C
Finland, Israel

Portfolio highlights

Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
IndoorAtlas — Discover the power of indoor positioning technology with IndoorAtlas. Build innovative indoor location-based solutions using our cross-platform SDK. Explore case studies and start developing today.

Aqua-Spark is an investment fund with a focus on sustainable aquaculture businesses around the world. The small-to-medium enterprises (SMEs) they invest in are working toward the production of safe, accessible aquatic life, such as fish, shellfish and plants, in ways that do not harm their oceans. Their investors value the fact that each investmentaims to create triple impact—specifically, each investment is chosen for its potential to generate significant financial returns while also activating positive environmental and social outcomes.Aqua-Spark believes that committing to a long-term vision is the way to realize effective and lasting impact results. When it comes to investments, they do not seek quick exits; instead, they look for entrepreneurs who strive to build and scale toward the future, who see their business as major economic opportunities that can also help solve looming environmental and food security challenges over the long-term. As an essential of each investee, Aqua-Spark seeks sustainability.

Investment focus

Biotechnology, Aquaculture, Seafood
Funding Round, Series A, Seed
United States, Norway, Israel

Portfolio highlights

Oceano Fresco — Oceano Fresco develops and produces bivalves varieties with superior performance for shellfish farmers at a competitive cost, respecting environmental sustainability and ensuring consumer safety.They use a multi-disciplinary approach including expertise in molecular biology, genetics, animal physiology, computational biology and intellectualproperty to select value adding traits to shellfish farmers and contribute to the sustainability and profitability of the aquaculture industry.They work with hatcheries, nurseries and research centers in order to test and validate their solutions and ensure that they suit the specific needs of each customer, in each technical and environmental context.
Kuehnle Agrosystems — Kuehnle AgroSystems curates a unique set of algae originating from pristine waters and ecosystems of Hawaii, as well as tropical botanical accessions representing plants prized by Polynesian voyagers.
Wanda Fish Technologies — Wanda Fish is an innovative FoodTech company with a platform that produces a wide variety of delicious fish fillets using sustainable cell-cultivation practices.

Fortum Oyj is a global learning and development firm specializing in strategy execution for companies in a broad array of industries.

Investment focus

Biotechnology
Series A
Finland

Portfolio highlights

Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.

Provide an effective, outsourced incubation and acceleration platform .

Investment focus

Electric Vehicle, Manufacturing, Energy
Funding Round, Seed, Pre-Seed
Finland, Norway

Portfolio highlights

Akkurate — Sandvik Battery Electric Loaders and Trucks TH550B LH518B Mobile Charging Station Battery as a Service
Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
The Human Touch Robotics — Automating online grocery and food related goods picking with single-item picking robots, through adaptive gripping and AI vision system.

Midinvest Management is a Finnish private equity firm specialized in ownership arrangements for small- and medium-sized enterprises.

Investment focus

Software, Information Technology, Internet
Seed, Funding Round, Convertible Note
Finland

Portfolio highlights

Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
Quosis — As of March 18, 2008, Quosis Oy was acquired by Proactum Oy. Quosis Oy operates as an open source software service company. It offers open-source based solutions and services, including portal solution for managing organizationâ€™s information and services; content management for gathering, sharing, saving, and producing information; businessprocess management for automating, monitoring, managing, and improving key processes; integration of information systems; and instant messaging for improving the organizational information exchange. The company also offers open source consultation and software development services. It serves the paper industry. The company was founded in 2004 and is headquartered in Jyvaskyla, Finland.
Howspace — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.

Oy Hammaren & Co Ab provides financial services and insurance activities.

Investment focus

Health Care, Wellness, GreenTech
Funding Round, Angel, Series A
Finland

Portfolio highlights

Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
Heltti — Heltti redefines occupational healthcare and well-being services with technology and a subscription model. Heltti develops the most lovable digital health care systems. Heltti is a Finnish occupational health care company founded in 2013. It is owned by its employees and a handful of renowned Finnish investors, such as Risto Siilasmaa.
NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.

We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.

Investment focus

Software, Health Care, Biotechnology
Series A, Funding Round, Series B
Germany, Switzerland, United States

Portfolio highlights

Ledgy — Digitize your cap table, automate equity plans and simplify compliance. Find out how leading companies use Ledgy to empower their employees and engage investors.
HeyJobs — Intelligent recruiting | more hires with performance marketing | only qualified candidates | fast recruiting success | over 1,500 companies use HeyJobs to find employees
Humanoo — HUMANOO | MAKING PEOPLE HEALTHIER! HUMANOO is the digital health platform for employees and insurance clients. We enable our users to improve their physical and mental health. Simple, effective, proven - all in one app. With customized programs and innovative eHealth solutions, we guide our users in the areas of fitness, physio, yoga, mindfulnessand nutrition to their self-imposed goals. For the first time, companies and insurance companies can use comprehensive decentralized analysis to understand the health of their employees or insurance clients and make it a measurable success. Our team currently consists of 65 employees from 15 nations with different talents. In our office in Berlin-Kreuzberg, software developers, designers, marketing and sales specialists work together with sports and nutrition scientists as well as yoga teachers and physiotherapists. What we share is the goal to motivate people to stay healthy.

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Investment focus

Biotechnology, Health Care, Medical
Series A, Funding Round, Series B
United States, United Kingdom, France

Portfolio highlights

Argá Medtech — Novel Sine Wave Technology Promises Significant Advantages Over Existing Pulsed Field Cardiac Ablation Systems
PIC Therapeutics — PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation.
Curve Therapeutics — Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve isdeploying this platform to build a pipeline of novel cancer drugs.

Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.

Investment focus

Health Care, Medical, Biotechnology
Seed, Pre-Seed, Series A
Finland

Portfolio highlights

Gosta Labs — Focus on care
Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
Nightingale Health — The most advanced health check for the health industry.

Nordea Bank is Denmark's second-largest bank and counts every fourth Dane among its customers. Through their nationwide network of some 340 branch offices and a broad range of self-service facilities, they are able to offer you a full scale of financial products and services, including Netbank, Online Investment, telephone banking and cashdispensers.

Investment focus

FinTech, Financial Services, Banking
Funding Round, Debt Financing, Seed
Finland, Sweden, Norway

Portfolio highlights

Tibber — Tibber is a digital electricity supplier that offers smart solutions to minimize their customers’ consumption and costs. Its vision is to make sustainable energy consumption simple and affordable for all households. Tibber's mission is to reduce the residential electricity consumption for European households by 20 %. Founded in Norway andSweden in 2016, the company has expanded its offer to Sweden and Germany where it powers hundreds of thousands of homes. Tibber replaces traditional utilities with smart technology, supplying its customers with renewable energy at fair and transparent prices. In addition, its app provides real-time analytics into energy usage, and pairs with a variety of smart home devices to reduce electricity consumption at home. The company sells tech-gadgets in their online store and recently was licensed to balance the main power grid in Sweden with EVs.
Statzon — Make data-driven plans & faster decisions with a simple access to +1M datasets & market reports about 8,000 topics from +200 trusted data providers.
Get It Done Now — GIDN is a Nigerian Fintech Company targeting medium and low income population for Loans and Financial products. GIDN has in addition a cashless, mobile based community marketplace, with more than 5k members, and aims to regulate the informal economy and facilitate the purchase of Services and Digital Products.

cross-border, healthcare, life science, investment, VC, China, US

Investment focus

Therapeutics, Biotechnology, Pharmaceutical
Series A
Finland

Portfolio highlights

Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.
Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.

Kiilto Ventures is a family-owned company. Kiilto invests strongly in growth and renewal, determined to keep on reinventing and challenging themselves beyond their present core business.

Investment focus

Construction, CRM, Hospital
Funding Round, Seed
Finland, Portugal

Portfolio highlights

Delox — Delox is a spin-off of the Faculty of Sciences of the University of Lisbon (FCUL), whose goals consist in the design, development, and production of a vast portfolio of automatic biodecontamination robots. Target applications include the sterilization of medical devices in hospitals, health centers and field hospitals (for humanitarian missions,catastrophe situations, and war zones); room biodecontamination in hospitals, pharma, food industry and space; and laboratory equipment biodecontamination.
Betolar — Betolar is a new materials startup specialized in new geopolymer-based carbon-neutral construction materials for the construction industry and circular economy.
Asumma Homes — Asumma Homes is a construction technology company that focuses on building a global brand in housing. It provides architectural design, configuration, customization, and construction engineering. Asumma Homes was founded in the year 2021.

The EU framework programme for research and innovation

Investment focus

Biotechnology, Health Care, Software
Grant, Seed, Funding Round
Spain, Switzerland, United Kingdom

Portfolio highlights

NovaMea — NovaMea is a cleantech startup that designs and commercializes electrochemical systems for energy storage and conversion.Its purpose is to create technology, services, and products for the storage and conversion of energy using electrochemical processes, as well as to produce, store, sell, and distribute these products and their components.
Perciv AI — Perciv provides artificial intelligence (AI)-based software solutions to unlock the latent possibilities of radars and allow resilient and economical autonomous systems with Lidar-like performance even in severe weather circumstances.
Neuron Soundware — Neuron Soundware uses Artificial Intelligence and Machine Learning in combination with the analysis of sound and other physical parameters.

Gaingels is a leading venture investment syndicate in support of diversity, inclusive of the LGBTQIA+ community and allies in the venture capital space.

Investment focus

Software, Health Care, Artificial Intelligence
Seed, Series A, Series B
United States, Canada, Mexico

Portfolio highlights

1up — 1up is a competitive AI for users to observe and understand everything their competitors are doing. 1up accelerates and automates the competitive experience for teams. 1up enables teams to save hours of manual effort in product, sales, and marketing, understand what their competitors are building and saying, and win competitive deals faster andeasier than ever before.
Holly — Equipping local governments with the tools to streamline hiring, optimize workforce management, and attract top talent. With deep expertise in civic innovation, our team understands the unique challenges facing HR departments and is committed to delivering powerful, data-driven solutions that save time and simplify processes.
Qnovia — Respira Technologies is a platform device and biotechnology company focusing on aerosol science. The company is creating breakthrough aerosol devices and formulations that safely deliver a broad range of pharmaceuticals and nicotine.Respira Technologies' mission is to create novel medical devices of unparalleled efficiency and to advance theprotection of public health with consumer devices through novel innovation, responsible sourcing, draft legislative proposals, transparent product information, and common sense oversight.

Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.

Investment focus

Food and Beverage, Food Processing, Biotechnology
Series A, Seed, Series B
United States, Israel, United Kingdom

Portfolio highlights

ENOUGH — ENOUGH makes protein sustainable by producing ABUNDA mycoprotein, made by fermenting fungi with the natural sugars from grains. It is a whole protein with all 9 essential amino acids & rich in fibre. It is a B2B ingredient, neutral in taste and fibrous in texture, like meat. The most sustainable
Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
Wanda Fish Technologies — Wanda Fish is an innovative FoodTech company with a platform that produces a wide variety of delicious fish fillets using sustainable cell-cultivation practices.

Metsola Ventures

Investment focus

Medical, mHealth, Health Care
Series A
Finland

Portfolio highlights

Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
Synoste Oy — Patient friendly and innovative solutions for correcting skeletal deformations.

Conor Venture Partners is a new breed technology venture capital fund and management company. Conor invests in early-stage companies originating from Nordic and Baltic countries. Investment areas include information and communications technology, embedded software, semiconductor technology, electronics, new materials and optics.

Investment focus

Software, Analytics, Semiconductor
Series A, Series B, Seed
Finland, United States, Sweden

Portfolio highlights

TactoTek — Set your imagination free and create user experiences with the help of sustainable smart molded structures.
Blackwood Seven | Part of Kantar Group — Attribute, predict and optimize the business outcome of marketing and media plans with Blackwood Seven's Unified Marketing Modeling platform.
Verto Analytics — Verto Analytics (Verto) operates a passive metering panel that provides researchers, advertisers, and publishers the data they need to keep up with the rapid and changing pace of consumer media consumption on every app, device, service, and platform. This ongoing, longitudinal panel captures a wide breadth of behaviors—all enriched to clients’behavioral analysis or custom survey studies. Our single-source, passive metering data sets provide the information needed to understand the full digital footprint of the U.S. population. Our Data Labs are located in the US, and in Helsinki, Finland. http://www.vertoanalytics.com.

Illusian is the Founder Office of people who have founded and scaled companies like Supercell, Zalando, Wolt, Aiven, Pigment, and Smartly. While the group is still busy running their businesses, they've aligned their networks, capital, and expertise to simultaneously support the next generation of builders.

Investment focus

Software, Artificial Intelligence, Information Technology
Seed, Series A, Series B
Finland, United States, Germany

Portfolio highlights

Droppe — Order work equipment directly from manufacturers. Support small businesses and source more responsibly from local and European manufacturers. Order from several suppliers at the same time with one shopping cart. Test samples for free and order products for your workplaces without extra hassle. Find nitrile gloves, protective clothing, work gloves, work accessories, disposable gloves, disinfectants, sanitizers and other supplies in one place.
Zero — Buy verified cash app account at the best IT service provider smmsellshop at cost-effective price, we provide SSN, Bank & Selfie verified accounts.
Realm — Realm is a search engine for the workplace reimagined with AI. Designed to help fast-moving teams better leverage their collective knowledge.

Zhejiang Huahai Pharmaceutical Co. Ltd. is a Phermaceutical Company.

Investment focus

Biotechnology, Pharmaceutical, Therapeutics
Series A
China, Finland

Portfolio highlights

Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
Yannuo Pharmaceutical — Yannuo Pharmaceutical is a high-tech enterprise focusing on the research and development of complex injections. It has three main drug research and development technology platforms: liposomes, nanoparticles, and microspheres. Relying on the advanced drug delivery technology platform, the company adheres to the clinical needs-oriented and conductsresearch and development of small molecule drugs, nucleic acid drugs, peptides, and protein drugs. Deepen development and industrialization, focusing on the tumor, contrast agents, anesthesia and pain, and other therapeutic areas.

Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Seed, Series B
United States, Canada, Israel

Portfolio highlights

Aria CV — Learn about Aria CV's novel implantable medical device designed to treat pulmonary hypertension (PH). Our elegant device has no battery, pump, or electronics.
Alveron Pharma — Alveron produces drugs such as cyclodextrins, pro-coagualant cyclodextrins with a unique coagulation platform technology.
CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.

The Stockholm Techstars Accelerator invests in early-stage, high-growth companies looking to build and expand in the Nordic-Baltic startup ecosystem.

Investment focus

Pet, FinTech, Finance
Pre-Seed
Israel, Norway, Sweden

Portfolio highlights

goscore — Fair human credit scoring, credit check, and assessment for you
Terrawaste — TerraWaste is a next-generation chemical recycling company that turns non-recyclable waste into value by creating new, climate-positive materials with a pollution-free process. TerraWaste focuses on lowering the level of need for virgin oil extraction by recycling plastics with chemical recycling technology 'htloop' into high-qualityclimate-positive crude oil, biochar, and high-value chemicals to support companies globally to become more sustainable and circular. Our technology (htloop) is developed on a process developed in the laboratory for over 20 years and hasn’t been commercialized until recently. TerraWaste is the first company to use HTL to recycle plastic waste and turn it into new plastic products. The unique thing is the state-of-the-art technological system that will recycle waste in a continuous-flow system, at the same time reusing heat and water in a loop, that way dramatically decreasing energy consumption. Our process is pollution free, and we produce carbon-negative output materials, that way offsetting other, carbon-heavy industries.
Five Letter Foods — Real food for dogs. Ultra-processed junk food is boring and makes your dog sick. Our meal kits have a full swing of variety. Death to kibble.

The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.

Investment focus

Software, Biotechnology, Information Technology
Seed, Series A, Funding Round
Germany, Switzerland, United States

Portfolio highlights

Pagent — Pagent develops AI systems.
AUDAVIS — AUDAVIS is developing the most innovative approach that will revolutionize auditing. With data-driven full automation by AUDAVIS and a new AI-based approach, every financial statement becomes a breeze with unprecedented efficiency.
Lindis Blood Care — Lindis Blood Care´s mission is to optimise the outcome of cancer surgeries by developing a Medical Device to remove cancer cells from blood during cancer surgeries to enable Autologous Blood Transfusion.

Moomin Official Site: discover Moominvalley and the magical characters created by Tove Jansson. Get the latest Moomin news and stories.

Investment focus

Biotechnology, Environmental Engineering
Seed
Finland

Portfolio highlights

Origin by Ocean — We rid the oceans of harmful algae and turn it into everyday goods.

Backing category-defining companies from inception to IPO.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Pre-Seed
United States, United Kingdom, Brazil

Portfolio highlights

E-Pal — E-Pal connects high-caliber gamers worldwide, offering you supportive gaming companions anytime, anywhere. You'll never battle alone!
Lightning AI — Seamlessly train hundreds of Machine Learning models on the cloud from your laptop
Hauler Hero — Hauler Hero is a waste management software solution that helps waste haulers improve their operations, increase efficiency, and reduce costs.

We are Valio Group: the most innovative dairy and food company in the world.

Investment focus

Life Science, Biotechnology
Series A, Series B
Finland

Portfolio highlights

Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.

We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.

Investment focus

Health Care, Software, Information Technology
Seed, Funding Round, Series A
Germany, United Kingdom, Finland

Portfolio highlights

Klim — Klim enables farmers to transition to regenerative agriculture at scale by providing them financial support, knowledge, documentation tools, and a community via our digital companion for farmers.Klim-verified carbon removal credits, generated by Klim farmers, help companies to transition to net zero by offsetting their carbon emissions locallyand with maximum impact and transparency.
OroraTech — OroraTech provides global real-time information services. The first target market is early detection and monitoring of wildfires, extended by a proprietary constellation of thermal imaging nanosatellites equipped with in-space AI image processing. At the beginning of 2020, OroraTech launched an MVP called Wildfire Service (WFS) that enables quickdetection and monitoring of wildfires on a global scale. The combination of existing thermal-infrared satellite data with external data layers, such as fuel, wind, and risk maps results in an automatic generation of fire alerts and the display of current fire perimeters for users. The MVP was launched in early 2020 and has gained increasing traction with governmental and large corporate customers all over the world.
Decade Energy — Decade Energy is the energy infrastructure and optimization partner for transport operators and depot managers who want to electrify their fleets.

Thames Trust

Investment focus

SaaS, FinTech, Finance
Seed, Series A, Series B
United Kingdom, Finland

Portfolio highlights

STEM — For makers, learners, and players. Creative computing projects, stories, and more.
Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
ABAKA Holdings — ABAKA is world's first digital saving and retirement enterprise SaaS platform, powered by Artificial Intelligence. Our innovative technologies enable financial institutions to power digital saving and retirement solutions and deliver scalable and affordable advice on pensions, savings and investments to their retail customers. ABAKA’s libraryof modular applications helps our enterprise clients to power conversational AI, personalised and behavioural nudges, big data insights, financial dashboards and outstanding customer experiences.Today over 9 million people have access to the ABAKA technologies through our clients, and our technologies are licensed by Tier one international banks, pension providers and asset managers across multiple countries.ABAKA’s enterprise solutions enable financial institutions to power: • Conversational AI: on pensions, savings and investments, for both fully digital and hybrid advice. The proprietary NLP models take vast quantities of user behavioural and financial data to intelligently manage a human like conversation. • Intelligent Behavioural Nudges: machine learning models to identify persona segmentation, power personalised insights and nudges to increase engagement and up-sell opportunities, across digital channels. • Digital financial dashboards: data aggregation technology powering Open Banking, Pension Tracing and Pension Dashboards. • Financial Planning Engine: retirement planning, cash flow modelling, suitability assessment, Monte-Carlo simulations for outcome & scenario driven advice

Athensmed Oy

Investment focus

Health Care, Medical, mHealth
Seed, Series A, Funding Round
Finland

Portfolio highlights

VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol

Investors by industry

Artificial intelligence